The reduction in price target by Morgan Stanley, a major financial institution, could lead to a negative short-term sentiment among investors, potentially causing a decrease in NYCB's stock price. The Equal-Weight rating suggests that the analyst sees the stock as adequately valued at its current price, but the lowered target indicates a revision of the stock's future valuation, which could impact investor confidence.